✦ LIBER ✦

Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A

✍ Scribed by V. Ann Stewart; Shannon M. McGrath; Douglas S. Walsh; Stacey Davis; Aaron S. Hess; Lisa A. Ware; Kent E. Kester; James F. Cummings; J. Robert Burge; Gerald Voss; Martine Delchambre; Nathalie Garçon; Douglas B. Tang; Joe D. Cohen; D. Gray Heppner Jr.

Book ID: 116959125
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 873 KB
Volume: 24
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2006.06.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of the RTS,S/A

Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1–4 in Mozambique

✍ E. Macete; J. J. Aponte; C. Guinovart; J. Sacarlal; O. Ofori-Anyinam; I. Mandoma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 535 KB

Four year immunogenicity of the RTS,S/AS

Four year immunogenicity of the RTS,S/AS02A malaria vaccine in Mozambican children during a phase IIb trial

✍ Pedro Aide; Carlota Dobaño; Jahit Sacarlal; John J. Aponte; Inácio Mandomando; C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 365 KB

A phase I/IIa safety, immunogenicity, an

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults

✍ Kent E. Kester; Denise A. McKinney; Nadia Tornieporth; Christian F. Ockenhouse; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 174 KB

A clinical trial of prime-boost immunisa

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS

✍ Susanna J. Dunachie; Michael Walther; Jenni M. Vuola; Daniel P. Webster; Sheila 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Randomized, controlled trial of the long

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02Dmalaria vaccine in infants living in a malaria-endemic region

✍ Salim Abdulla, Nahya Salim, Francisca Machera, Richard Kamata, Omar Juma… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 243 KB

Safety, tolerability and immunogenicity

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21

✍ Oscar Kashala; Roberto Amador; Maria V. Valero; Alberto Moreno; Arnoldo Barbosa; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 206 KB